[SCENARIO] id=112 | sector=health | agents=3 | rounds=20
[AGENTS] 1=Infection Prevention & Control (IPC) Director, 2=Environmental Services (EVS) Operations Manager, 3=Supply Chain Contracting Director
[GOAL] Produce a final recommendation for a 60-day remediation plan to reduce hospital-onset C. difficile infections across a 4-hospital system, balancing infection-control effectiveness, EVS operational feasibility, and supply/contract constraints (including whether to switch to sporicidal disinfectants and how to sequence training, monitoring, and procurement).

[R0.1] Infection Prevention & Control (IPC) Director (speak, public): To effectively reduce our hospital-onset C. difficile infections, we need to examine our current cleaning performance. I would like to discuss the latest cleaning effectiveness audit results, which showed a UV marker removal rate of only 71% across 18 units, against our target of 85%. Can we explore what operational challenges might be affecting this? Additionally, I want to understand if there are any constraints in procuring sporicidal disinfectants that could impact our remediation plan.
[R0.2] Environmental Services (EVS) Operations Manager (speak, private to=Infection Prevention & Control (IPC) Director): In reviewing our cleaning performance metrics, I can share that our median terminal clean cycle time is currently 62 minutes per discharge against a target of 55 minutes. Additionally, our disinfectant dwell-time adherence is at 54% for the required 10 minutes. These factors could be contributing to the UV marker removal rate issue you've noted. Regarding the procurement of sporicidal disinfectants, I’d like to understand any potential budget impacts and supply reliability. Can you provide insight on that?
[R0.3] Supply Chain Contracting Director (speak, public): It's crucial that we address the operational challenges impacting our cleaning effectiveness. Based on our current contract, we are using QuatClean Plus across all four hospitals, which has a significant annual spend of $312,000. Transitioning to sporicidal wipes could enhance our infection control efforts, but it would add approximately $28,000 to our monthly expenses. Additionally, I can confirm that our supplier can provide 3,500 canisters of sporicidal wipes per week with a lead time of 14 days. I would like to hear more about the specific operational challenges you're observing that might be influencing the UV marker removal rates and how we can ensure readiness for a potential switch in products.

[R1.1] Infection Prevention & Control (IPC) Director (speak, public): Thank you both for sharing these insights. It's clear we have some operational challenges to address, particularly with the cleaning cycle times and disinfectant dwell-time adherence. The increase in monthly expenses for sporicidal wipes is concerning, but if it significantly improves our infection control efforts, it may be worth considering. I suggest we collaborate closely to analyze these metrics further and ensure we can implement an effective remediation plan. Can we set a follow-up meeting to discuss specific strategies and timelines for these changes?
[R1.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R1.3] Supply Chain Contracting Director (speak, public): I agree, a follow-up meeting would be beneficial. Let's schedule a time to dive deeper into the cleaning cycle times, disinfectant dwell-time adherence, and how we can ensure operational readiness for the potential transition to sporicidal wipes. I'd also like to discuss any additional metrics we should be tracking to support our remediation plan.

[R2.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R2.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R2.3] Supply Chain Contracting Director (leave, public): 

[R3.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R3.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R3.3] Supply Chain Contracting Director (leave, public): 

[R4.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R4.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R4.3] Supply Chain Contracting Director (leave, public): 

[R5.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R5.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R5.3] Supply Chain Contracting Director (leave, public): 

[R6.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R6.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R6.3] Supply Chain Contracting Director (leave, public): 

[R7.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R7.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R7.3] Supply Chain Contracting Director (leave, public): 

[R8.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R8.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R8.3] Supply Chain Contracting Director (leave, public): 

[R9.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R9.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R9.3] Supply Chain Contracting Director (leave, public): 

[R10.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R10.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R10.3] Supply Chain Contracting Director (leave, public): 

[R11.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R11.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R11.3] Supply Chain Contracting Director (leave, public): 

[R12.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R12.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R12.3] Supply Chain Contracting Director (leave, public): 

[R13.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R13.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R13.3] Supply Chain Contracting Director (leave, public): 

[R14.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R14.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R14.3] Supply Chain Contracting Director (leave, public): 

[R15.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R15.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R15.3] Supply Chain Contracting Director (leave, public): 

[R16.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R16.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R16.3] Supply Chain Contracting Director (leave, public): 

[R17.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R17.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R17.3] Supply Chain Contracting Director (leave, public): 

[R18.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R18.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R18.3] Supply Chain Contracting Director (leave, public): 

[R19.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R19.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R19.3] Supply Chain Contracting Director (leave, public): 

